Taysha Gene Therapies, Inc. (TSHA) KPIs and segments
TSHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.00−0.06 (-1.48%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Taysha Gene Therapies's business
Coming soon
This tab will track the numbers specific to Taysha Gene Therapies's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?